TP53 and malignant colon neoplasm: Notably, in the non-hypermutated human colon cancer, about 80% of tumors that carry missense mutations lost wild-type TP53 genes via loss of heterozygosity (LOH) (The Cancer Genome Atlas Network, 2012).